Benefit–Risk Profile of Sphingosine-1-Phosphate Receptor Modulators in Relapsing and Secondary Progressive Multiple Sclerosis
Crossref DOI link: https://doi.org/10.1007/s40265-017-0814-1
Published Online: 2017-09-13
Published Print: 2017-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Comi, Giancarlo
Hartung, Hans-Peter
Bakshi, Rajesh
Williams, Ian M.
Wiendl, Heinz
License valid from 2017-09-13